
Carl Feng
@fenglab_usyd
Immunologist @Sydney_Uni interested in host defence against infection
ID: 1550765062453075968
23-07-2022 08:50:49
68 Tweet
158 Followers
105 Following

.Taylor Foreman, Daniel Barber, PhD et al. NIAID News find that, in mice, CD30 drives T cell differentiation & is required for host survival of Mycobacterium #tuberculosis infection, showing T cell immunity to Mtb requires CD30-dependent co-stimulation. bit.ly/3L5EOoT



Excited to share the first preprint from my lab 🎉 In close collaboration with Ellis Patrick we share MoleculeExperiment - R/Bioconductor class for molecule-resolved spatial transcriptomics Congratulations to Bárbara Zita Peters Couto for her work on this exciting project!

PhD opportunity available in my lab. Please see the link below and RT. Mater Research Translational Research Institute UQ Medicine graduate-school.uq.edu.au/project/oxidis…


Proud to share my former PhD student Lina Daniel second paper on lung-draining lymph node in #TB infected mice, so much to learn! Sydney Health Sydney ID Charles Perkins Centre Centenary Institute journals.plos.org/plospathogens/…



Exciting work from Kerry Hilligan on new regulatory function of IFNg in production against #COVID19 !

New research shows naïve lymphocytes can enter lung-draining lymph nodes through an alternative pathway during Mycobacterium tuberculosis infection. Read the study from researchers at Sydney Health: plos.io/3Q2GTpT #Immunology #Tuberculosis #LymphocyteTrafficking


Our article "No evidence of durable trained immunity after two doses of adenovirus-vectored or mRNA COVID-19 vaccines" is out now as an online preview in Journal of Clinical Investigation. Thanks to Flinders Foundation and Bioplatforms Australia for funding jci.org/articles/view/…



We are looking for young (18-35) healthy adults in Adelaide to join this unique NHMRC-funded vaccine study. If you’re in Adelaide, or know people there, please share widely through your networks SAHMRI FlindersHMRI Flinders University South Australian Genomics Centre (SAGC)

📢 Bacterial-induced or passively administered IFNg protects against #COVID19 in 🐭 by arming the 🫁 epithelium with viral restriction factors. Check out our new paper in Nature Communications here: nature.com/articles/s4146… Summary from NIAID News below 👇



Check out our latest paper science.org/doi/10.1126/sc…. Congratulations to Evangelos Giampazolias who led the work. Thanks to very many who helped. Great collaboration with Tine Jess and Romina Goldszmid labs. Tweetorial will follow soon.

